The primary endpoint was change from baseline in 23-h weighted mean glucose ( WMG ) ; secondary endpoints included change from baseline in fasting plasma glucose ( FPG ) , insulin resistance ( Homeostatic Model Assessment [ HOMA-IR ] ) , insulin secretion ( HOMA - % B ) and body weight .